Diabetic Retinopathy

Bio-Pharma

REGENXBIO Doses First Patient in NAAVIGATE Gene Trial

ROCKVILLE, Md., June 29, 2026 REGENXBIO Inc. has reached a major milestone in the advancement of gene therapy for...

By cGxPwire Editor
June 30, 2026

Bio-Pharma

Lupin Wins FDA Approval for Ranluspec Biosimilar Eye Drug

Mumbai, India and Naples, Florida, June 5, 2026 Global pharmaceutical company Lupin Limited has secured a major regulatory milestone...

By cGxPwire Editor
June 8, 2026

Bio-Pharma

Nona Biosciences Appoints Josh Xiao as New CSO

CAMBRIDGE, Mass., May 6, 2026 Nona Biosciences, a global biotechnology company specializing in biotherapeutic discovery and AI-driven drug development...

By cGxPwire Editor
May 7, 2026

M&A

Bayer to Acquire Perfuse Therapeutics in $2.45B Deal

BERLIN, Germany, and SAN FRANCISCO, Calif., May 6, 2026 Bayer has announced an agreement to fully acquire Perfuse Therapeutics...

By cGxPwire Editor
May 7, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Diabetic Retinopathy

REGENXBIO Doses First Patient in NAAVIGATE Gene Trial

Lupin Wins FDA Approval for Ranluspec Biosimilar Eye Drug

Nona Biosciences Appoints Josh Xiao as New CSO

Bayer to Acquire Perfuse Therapeutics in $2.45B Deal